Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Witte

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ringJohn R Koenig, Huaqing Liu, Irene Drizin, et al.
Practical Radiation Oncology|February 19, 2025
Variations in Radiation Therapy Delineation of the Lateral Compartments in Patients with Rectal Cancer: Results After an Updated National GuidelineEline G M van Geffen, Tania C Sluckin, Marnix G Witte, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effectsTimothy A Esbenshade, Kathleen M Krueger, Thomas R Miller, et al.
Neurosurgery Practice|October 30, 2025
Resection Location and Work Resumption in Patients With Lower-Grade Glioma: A Multicenter Cohort StudyIvar O Kommers, Maisa N G van Genderen, Roelant S Eijgelaar, et al.
Journal of Neuroscience Methods|August 10, 2010
Comparing levels of biochemical markers in CSF from cannulated and non-cannulated ratsSteven C Cassar, Ann E Tovcimak, Nathan R Rustay, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2007
An 80-amino acid deletion in the third intracellular loop of a naturally occurring human histamine H3 isoform confers pharmacological differences and constitutive activityGerold Bongers, Kathleen M Krueger, Thomas R Miller, et al.
Journal of Medicinal Chemistry|August 8, 2008
The alkaloid conessine and analogues as potent histamine H3 receptor antagonistsChen Zhao, Minghua Sun, Youssef L Bennani, et al.
European Journal of Pharmacology|March 23, 2004
Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonistArthur A Hancock, Youssef L Bennani, Eugene N Bush, et al.
Biochemical Pharmacology|August 6, 2004
Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonistTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ringJohn R Koenig, Huaqing Liu, Irene Drizin, et al.
Practical Radiation Oncology|February 19, 2025
Variations in Radiation Therapy Delineation of the Lateral Compartments in Patients with Rectal Cancer: Results After an Updated National GuidelineEline G M van Geffen, Tania C Sluckin, Marnix G Witte, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effectsTimothy A Esbenshade, Kathleen M Krueger, Thomas R Miller, et al.
Neurosurgery Practice|October 30, 2025
Resection Location and Work Resumption in Patients With Lower-Grade Glioma: A Multicenter Cohort StudyIvar O Kommers, Maisa N G van Genderen, Roelant S Eijgelaar, et al.
Journal of Neuroscience Methods|August 10, 2010
Comparing levels of biochemical markers in CSF from cannulated and non-cannulated ratsSteven C Cassar, Ann E Tovcimak, Nathan R Rustay, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2007
An 80-amino acid deletion in the third intracellular loop of a naturally occurring human histamine H3 isoform confers pharmacological differences and constitutive activityGerold Bongers, Kathleen M Krueger, Thomas R Miller, et al.
Journal of Medicinal Chemistry|August 8, 2008
The alkaloid conessine and analogues as potent histamine H3 receptor antagonistsChen Zhao, Minghua Sun, Youssef L Bennani, et al.
European Journal of Pharmacology|March 23, 2004
Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonistArthur A Hancock, Youssef L Bennani, Eugene N Bush, et al.
Biochemical Pharmacology|August 6, 2004
Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonistTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Pageof 16